Objectives: The total body of evidence finds fluoride varnish effective to prevent caries. However, most trials were conducted in high-risk populations, with more recent trials on low-risk groups finding a lower efficacy. We aimed to assess the cost-effectiveness of fluoride varnish application in clinic setting in populations with different caries risk.
on an individual and a population level. 3 In Germany, for example, ; costs in other settings might well differ and be higher, depending on national pricing.
The cost-effectiveness of applying fluoride varnish will depend not only on the costs for delivery, but also the possible savings associated with averted caries increment which may otherwise have led to restorations. If fluoride varnish is indeed highly effective, such savings could eventually even offset the initial application costs.
Such effectiveness and cost-effectiveness do not seem to be realized in all groups provided with the varnish or, more generally, preventive services. 5 To truly quantify the cost-effectiveness, investigators should fully incorporate the sequelae of restoration placement for a new carious lesion (such as renewing the restoration or replacing it with a crown). This "redentistry" has been found to be the relevant driver of costs, as it is usually more complex and expensive than initial treatments. 6, 7 Moreover, the efficacy of the varnish in contemporary populations needs to be considered, with more recent trials finding only very limited or no health benefit from fluoride varnishes. [8] [9] [10] [11] [12] [13] A number of health economic studies have found fluoride varnish applications to be beneficial for health, but costlier than not providing fluoride varnish. [14] [15] [16] [17] None of these studies fully incorporated the full sequence of events following a lesion development or considered the likelihood of differential efficacy of varnishes in populations with different caries risk. We aimed to assess the cost-effectiveness of fluoride varnish application in clinic setting using a mathematical model which allows the simulation of teeth followed until extraction and beyond.
2 | ME TH ODS
| Setting, perspective, population, horizon
This study adopted a mixed public-private-payer perspective in the context of German health care. The mixed public-private-payer perspective was selected because it is the most common in Germany.
To simulate the health and cost effects of fluoride varnish in different risk groups, we followed a population of initially 6-year-old individuals over their lifetime using a decision tree model constructed via TreeAge Pro 2013 (TreeAge Software, Williamstown, MA, USA).
As only permanent teeth were considered, the initial age of 6 years (eruption of the first permanent molars) was chosen. The model accounted for new carious lesions developing if no fluoride varnish was applied, and for the efficacy of fluoride varnish in preventing new lesion occurrence in different populations.
| Comparators and effectiveness of varnish
We compared two strategies: (i) no application of fluoride varnish; or
(ii) application of fluoride varnish by a dental provider (dentists or dental nurse) in a clinic setting (ie a pricing context at which the relatively high costs for running a dental office or clinic need to be covered; this is explicitly different from other settings such as schools). Fluoride varnish application was assumed to generate costs, but also to reduce the caries increment (new decayed, missing, filled surfaces in permanent teeth, DMFS). The data needed to determine the efficacy of fluoride varnish (that is, the relative reduction in caries increment) were derived from the most recent systematic
Cochrane review, 1 which we updated as described in the Appendix ( Figure S1 , Table S1 ). Based on the included studies, random-effects meta-analysis and meta-regression analysis were performed to assess the relative reduction in caries increment in different populations, with odds ratios being used to describe this reduction. Populations were assumed to be best characterized according to their annualized caries increment. This increment was measured as the DMFS in the control group which had not received fluoride varnish. For studies reporting on DMFT instead of DMFS increment, we assumed the DMFS to be 1.2 times higher than the DMFT, as has been reported for paediatric and adolescent populations.
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For meta-analysis, the unit of analysis was the comparison made, because this allowed to overcome possible unit of analysis issues (see Appendix). Note that this approach ignores the possible correlation of patients in the same study and could affect the weighting of studies. While the overall synthetic effect showed a significant Using the included studies, we also determined which frequency and duration of fluoride varnish application were most common. Varnish was assumed to be applied twice yearly in the base-case scenario. The costs of applying the varnish more or less often were assessed in a sensitivity analysis. While a dose-response gradient between fluoride concentration and effect seems likely, 19 there were insufficient data for determining exactly whether a different application frequency was also associated with different effectiveness. We thus assumed that the effectiveness did not differ by application frequency. In the base-case, we assumed the varnish to be provided until age 18, as is common and reimbursed by the public health insurance in Germany. 20 After this age, the caries increment was not assumed to differ any longer between test and control group. In a sensitivity analysis, we also modelled an application of the varnish for longer which prolonged the effectiveness, but also the costs.
| Model and assumptions
As mentioned, we initiated the simulation by age 6, assuming the first permanent molars to have erupted. Incisors were assumed to have erupted by age 8, premolars and canines at 10, and second SCHWENDICKE ET AL. were derived from a birth cohort study from New Zealand, which had found a nearly constant rate of DMFS/DMFT increment between ages 5 and 38 years when adjusted for surfaces at risk. 18 To account for the different risks, the caries increments in the 20th, the 62th and the 87th percentile of those individuals were used to estimate increments in different groups. These percentiles accounted for the identified three trajectories of low, medium and high increment in the original study. These groups were also found to be in accordance with the defined risk groups within the described meta-analysis. Person-level increments were transformed into hazard functions, accounting for the decreasing number of teeth at risk. The values yielded by our model when applying these functions were validated against repeated cross-sectional data on caries experience from Germany, 21 with the LR population being largely representative of today's 12-year-olds and 35-to 44-year-olds. These age groups have mean DMFT values of 0.5 and 4.9 carious, filled or missing teeth, respectively. One should note that the medium and high increment groups both present rather high-risk individuals within the 2016 German setting. We then used the synthesized estimates from our meta-analyses to adjust the annual caries increment in the test populations which were receiving fluoride varnish applications.
We assumed that a given caries increment would result in the provision of a two-surface adhesive composite restoration, which is a simplification but avoids the additional modelling of different surfaces. After placing the restoration, the tooth was considered at risk for further complications, which had been estimated by previous studies 6, 22 and are briefly described here. First, the placed restoration was assumed to be at risk for restorative complications (such as fracture, secondary caries). We assumed that repair of the restoration would first be attempted, followed by renewal in case of subsequent complications, followed by placement of a crown, or extraction in very few cases. Crowns were assumed to experience complications leading to recementation or renewal, or extraction as well (again, in only a few cases). Second, teeth were at risk of endodontic complications leading to nonsurgical primary or secondary root-canal treatment or surgical retreatment (that is, apicotomy) or extraction. Third, for extracted teeth, we assumed 50% of teeth to be subsequently replaced using implant-supported crowns.
As the replacement rate might be higher in Germany, 23 we additionally modelled 80% replacement. To increase the applicability of our findings to settings with lower replacement rates, a 20% rate was also modelled. Implants and implant-supported crowns were F I G U R E 1 Forest plot. Randomized control trials on fluoride varnish were meta-analysed in groups of different caries increment using random-effects meta-analysis. Effect estimates (that is, the risk of lesion development in the fluoride vs the nonfluoride group) are shown for each study, with squares and lines indicating odds ratios (OR) and 95% confidence intervals, respectively. The weights of studies are indicated by squares. Diamonds indicate the synthesized effect estimates in different groups (low, medium, high risk; abbreviated as LR, MR, HR). Studies with very low estimates (that is, outliers outside the scale of the Figure) are shown by left arrows only. Note that some studies employed fluoride varnish in more than one arm. We accounted for that accordingly and handled each comparison as single studies, which is why studies appear multiple times in the plot.
assumed to experience restorative complications (requiring recementation or renewal of crowns) as well as biologic complications (such as peri-implantitis with subsequent implant loss) or technical ones (such as abutment or implant fracture).
Parts of this model have been applied previously 3 to estimate the expected value of perfect information on fluoride varnish application. Thus, the model has been validated before. As described, we nevertheless validated it against observational data, but also by varying key parameters to check their impact on the results, by evaluating different model structures, and by performing sensitivity analyses.
| Health outcomes and measurement of effectiveness
Our primary health outcome was caries increment in DMFT. Our secondary health outcome was tooth retention years; that is, the mean time a tooth was retained in a patient's mouth. These health outcomes were determined by the empirical probabilities of tooth transition from one health state to another.
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| Resources and costs
Cost calculations were performed from a mixed public-privatepayers' perspective and have been described in detail elsewhere. 3, 24, 25 In Germany, costs for dental procedures are estimated using the German public and private dental fee catalogues, Bewertungsmaßstab (BEMA) and Geb€ uhrenordnung (GOZ), respectively. 20, 25 The majority of patients in Germany (87%) are enrollees in the statutory insurance, 26 with most fee items being drawn from the public catalogue (BEMA). Only fee items not or not fully covered by the public insurance (such as nonsurgical endodontic retreatment, crowns or implant therapies) are drawn from GOZ, and patients pay these fees out of their own pocket. For privately insured patients, all items are drawn from GOZ. Our estimates do not fully apply to these patients, but costs have been found to differ very little when estimated from private instead of public catalogues. 22, 27 Costs for items from the private catalogue are factorized to account for the complexity and time needed. The most frequently used factor is 92.3; that is, basic fee remuneration is uplifted by 2.3. 28 This was also used for this study. For fluoride varnish, one BEMA fee item (Individual Prophylaxis IP4) is claimed, with 11.46
Euro being charged per application until age 18, when payment is no longer covered by the public insurance. This is also equivalent to adolescents leaving the free community or school dental services of many countries. Afterwards, the GOZ item (1020) is claimed, at 6.47
Euro per application when using the standard factor. All other costs per treatment are sums of different items (for example for anaesthesia, rubberdam and composite restoration). A summary of cost estimates can be found in the Appendix (Table S2 ). Given the lack of primary data, opportunity costs of patients' time in treatment were not included. 
| Analytical methods
Monte Carlo microsimulations were used, with 1000 independent individuals being followed over the average expected life time of patients 30 in annual cycles. Using estimates for costs (c, in Euro) and effectiveness (e, as DMFT or years), incremental cost-effectiveness ratios (ICERs) were calculated, which express cost differences per effectiveness differences. Note that ICERs indicate differences in the more costly treatment compared with the less costly option. Positive
ICERs indicate additional costs per additional effectiveness unit.
Negative ICERs indicate lower costs at higher effectiveness, which means that there is no decision problem.
To introduce parameter uncertainty, several univariate sensitivity analyses were performed. Moreover, we randomly sampled a number of variables from uncertainty distributions. 31 The net monetary benefit of each strategy combination was calculated as k9ΔeÀΔc, with k denoting the ceiling threshold of willingness-to-pay; that is, the additional costs (c) a decision maker is willing to bear for gaining an additional unit of effectiveness (e). 32 If k>Δc/Δe, an alternative intervention, is considered to be more cost-effective than the comparator despite possibly being more costly. 31 We used this approach to calculate the probability of fluoride varnish being cost-effective for payers with different willingness-to-pay ceiling thresholds.
| RESULTS
Estimated effectiveness parameters, that are relative risks and transition probabilities, are summarized in Table 1 
| Sensitivity analyses
The first parameter we varied was the costs for applying the varnish.
In LR, we found the cost threshold to be 1.19 Euro per varnish application ( Figure 2B) ; only below such costs would fluoride varnish also be the less costly option in this group (note that this is 90% below the costs assumed in the base-case analysis). In MR, this value increased to 3.11 Euro ( Figure 2D ). In HR, this value was near the costs at 10.19 Euro ( Figure 2F ).
In further sensitivity analyses, we assessed how different application intervals would affect the cost-effectiveness. We found that an application only once per year lowered the ICER significantly, with varnish being more effective and less costly under such assumptions in the HR group (Table 2 ). If applied four times per year, the ICER ranged between 154 and 726 Euro per averted DMFT (Table 2) .
Similarly, varying the replacement rates had an influence on costeffectiveness ( Table 2) . At higher replacement rates, fluoride varnish was more cost-effective. Assuming the varnish to be applied lifelong substantially increased the costs. Despite the effectiveness increasing as well, the resulting ICER was higher in all groups than in basecase, indicating that such lifelong application is less cost-effective than application only in adolescence. Using the fixed-effects metaanalytic estimates had only limited impact, as did varying the discounting rates between 0% and 5% (not shown).
When using tooth retention years as a health outcome parameter, varnish had nearly no health benefit in LR, where teeth were retained for 70.0 and 69.8 years, respectively. In MR and HR, fluoride varnish application during adolescence allowed teeth to be retained for 0.5 and 2.4 years longer (respectively) than with no varnish application.
In HR, the ICER was 9 Euro per additional tooth retention year.
| DISCUSSION
The aim of this study was to assess the cost-effectiveness of in- From various health states, transitions to other health states were possible in our model. The probability and the sources of these transitions are given. We also show to which health states teeth were allocated in case of transition and the probability of allocation. Uncertainty distributions are also shown. These should be read as factors which are applied to randomly decrease or increase the probabilities with each simulation to reflect the uncertainty about the probabilities. RR Relative risks compared with no varnish application.
additionally spent per avoided carious tooth. The greatest benefit of fluoride varnish occurred in adolescence, with health gains coming at substantial costs if varnish was applied lifelong.
In contrast to the very clear effectiveness of fluoride varnish applications in the past, 33 recent studies present a mixed picture of their effectiveness. This is not primarily due to possibly underpowered studies or varnishes with lower concentrations resulting in lower effectiveness, but it may be due to the low caries experience in children, adolescents and even adults in many advanced market economies. 34 Moreover, besides differences in caries levels among countries, there are increasing differences or inequalities among populations within countries, again with differential effectiveness being likely in those populations. 35 It is, for example, very likely that the populations included in randomized control trials these days are highly selected and not those who are at risk. In line with this is the argument that the populations receiving fluoride varnish or other preventive dental procedures in the clinic setting are not necessarily those most at risk, with those preventive procedures not necessarily being greatly beneficial. 36 Finally, it has been argued that, given the large number of different varnishes available and the acknowledged variability in their formulation and effectiveness, the lower effectiveness of fluoride varnish might be specific to certain brands. 37 We could not show such an association; however, it is important to consider that this does not serve as evidence of absence but rather as a possible absence of evidence because of the lack of statistical power for such an analysis.
The outcome of this differential and setting-specific effectiveness is reflected in our cost-effectiveness findings. In HR, the costs for applying the varnish were nearly compensated by avoided cost for further treatments along the restorative cycle including crowns and tooth replacements, as could be shown when varying tooth replacement rates. Such cost-compensation has been reported before, which highlights the need to assess not only initial, but also longterm treatment costs when evaluating the cost-effectiveness of caries-associated interventions. 38 In general, our findings underline the F I G U R E 2 Cost-effectiveness acceptability curves and sensitivity analyses in low-(A,B), medium-(C,D) and high-risk groups (E,F). Left panel (A,C,E): With an increasing willingness-to-pay ceiling threshold, payers find fluoride varnish more likely to be cost-effective. This value decreases with increasing risk. Right panel (B,D,F): Similarly, with increasing costs for fluoride varnish, the incremental cost-effectiveness ratio (ICER) increases in disadvantage of the varnish group. Below certain costs per varnish application, placing a varnish is not only more effective, but also less costly than placing no varnish (as follow-up treatments are avoided); the ICER is consequently negative (no decision problem). This value is lower in low-risk than high-risk groups. Above this value, the ICER is positive, as varnish is more effective, but also more costly.
[Colour figure can be viewed at wileyonlinelibrary.com] SCHWENDICKE ET AL.
need for setting-specific analyses of effectiveness and cost-effectiveness. 39 Cost-effectiveness was also found to depend on the cost of delivery per application. Varnish was cost-effective in LR, MR and HR as long as the cost of application was <1. 20, 3.12 and 10.20 Euro, respectively. Hence, if the costs were below 1.20 Euro per application in LR, varnish application was cost-neutral. The current costs for in-office application in the German healthcare setting are likely to range between 6 and 12 Euro, highlighting that this particular application in this specific setting is cost-effective only for payers willing to invest additional money for health gains. Only in community programmes can lower costs be achieved, due to the application to larger groups in classrooms. It should be highlighted that in other settings than Germany, it might also be possible to reduce costs in clinic settings by having other providers (dental nurses, for example) applying the varnish; in Germany, this would not change costing as fee items would remain identical. Generally, however, there is also revent evidence from other countries that such preventive programme in clinic settings is effective, but also demands payers with a substantial willingness-to-pay for avoided carious lesions. 40 Finally, we found that the greatest cost-effectiveness occurred in adolescence, with only limited health gains at substantial costs if varnish is applied lifelong. Caution is needed when interpreting this finding, as it might be due to the parameterization of the caries increment.
Given that the underlying epidemiologic study found a near-linear increase in caries experience per available surfaces, we modelled a decreasing increment given that a reducing number of surfaces are available over a lifetime. If, however, the general risk profile changes (and with it, the annual increment per surface)-which is conceivable during the life course-such an assumption might not hold true, which could mean that varnish application in other life periods outside adolescence might be worthwhile too. One example of such a period might be the provision of fluoride varnish to prevent root caries in patients with gingival recession due to generalized bone loss. 41 Our study has a number of limitations. First, it might be that the currently low caries levels in the low-risk population are achieved partially by existing fluoride varnish programmes in the community dental system. Nevertheless, our findings would be applicable here, as the additional in-office application of varnishes (which, as discussed, is frequent) is not cost-effective in these populations. It can further be noted that, other than community or school-based programmes, an in-office application is unlikely to resolve the discussed equity issue. Second, and as discussed, our analyses built on artificially constructed risk groups using data from (i) caries increments in control group from RCTs and (ii) trajectories of caries in a birth cohort. It is very likely that other birth cohorts will have other trajectories; however, we validated our findings against current cross-sectional data and found it applicable. Similarly, we assumed that risk profiles would remain constant over an individual's lifetime, which is certainly a simplification, given that upward or downward social mobility has been shown to lead to changes in caries increment. 42, 43 Third, the costs in our study were derived from fee items and are likely to differ if microcosting was applied. 17 Costs will differ in other countries or depend on setting and who applies the varnish (as discussed, application costs might be lower in a community setting).
Fourth, we used the tooth-level caries increment to estimate costs for restorative (and other) treatments. This was done because it Costs (c) and effectiveness (e) are displayed. The incremental cost-effectiveness ratio (ICER) expresses the additional costs per gained or lost effectiveness. Negative ICERs are not shown, as they indicate varnish being more effective and less costly (no decision problem). avoids more complex surface-level models, while it needs mentioning that, in reality, dentists might place a number of restorations within the same tooth. Our costs are thus likely to be minimally distorted.
A number of recommendations arise from this study. First, future studies investigating the effectiveness and cost-effectiveness of caries-preventive regimens are encouraged to introduce risk aspects into their assessment. It is unlikely that, at least in most highly developed countries with considerable polarization in caries experience, a preventive strategy will be equally effective or cost-effective in all populations. In this sense, future meta-analysis should account for this aspect too. 1 Second, our evaluation might need repetition in another setting (and possibly using a different costing approach) to assess the robustness of our findings, especially in regard to the magnitude of the resulting ICERs. Third, national health programmes should, at least from a cost-effectiveness perspective, focus on inoffice fluoride application only in risk groups, not across all populations, and should seek to develop or expand less costly (and possibly also equity-beneficial) preventive regimens for high-risk populations.
In conclusion, and within the limitations of this study, application 
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